Dr. Christos P. Argyropoulos, MD, PhD

Dr. Argyropoulos practices at Dialysis Clinic Inc. in Albuquerque, New Mexico.

Dr. Argyropoulos' NPI, 1194968529, was assigned on April 15, 2009. Dr. Argyropoulos holds New Mexico license MD2014-0051.

Dr. Argyropoulos' primary practice is Dialysis Clinic Inc., at 933 Bradbury SE Dr, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 285-5200.

Dr. Argyropoulos' primary practice is Dialysis Clinic Inc. in Albuquerque, New Mexico. Dr. Argyropoulos is also affiliated with University of New Mexico Hospital. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Argyropoulos to 1 more hospital and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Argyropoulos practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Argyropoulos' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Argyropoulos is licensed in New Mexico.

CMS data shows 331 Medicare services from Dr. Argyropoulos across 6 procedure codes in 2024, for 166 Medicare patients. Medicare paid $51,534 for them.

CMS counts 166 Medicare patients who saw Dr. Argyropoulos in 2024. The largest group is under 65, with 62 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 5.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Argyropoulos' median patient age at 70, with 48% women.

In 2024, Dr. Argyropoulos wrote 953 Medicare Part D claims for 189 patients. 75% of them were for generic drugs. CMS names the drug for 669 of them, across 25 drugs with 11 or more claims each, at $113,096 in total drug cost. In 2023, CMS named 786 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Argyropoulos for performance year 2024, reported as part of a group. Dr. Argyropoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 105 papers to Dr. Argyropoulos, published from 2010 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Renal Insufficiency, Chronic. Dr. Argyropoulos has published most often in J Clin Med. Dr. Argyropoulos' most frequent co-authors are Mark Robert Rohrscheib, MD, Eduardo K. Lacson, MD, MPH and Susie Q. Lew, MD.

CMS Open Payments shows 35 general payments to Dr. Argyropoulos from 9 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 89% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $11,006. It also lists 12 research payments totaling $1,078 in 2019.